Author Affiliations1Research Institute of Clinical and Experimental Lymphology – Branch of Federal Research Center Institute of Cytology and Genetics of SB RAS 630060, Novosibirsk, Timakov str., 2
2Research Institute of Clinical and Experimental Lymphology – Branch of Federal Research Center Institute of Cytology and Genetics of SB RAS 630060, Novosibirsk, Timakov str., 2
3Research Institute of Clinical and Experimental Lymphology – Branch of Federal Research Center Institute of Cytology and Genetics of SB RAS 630060, Novosibirsk, Timakov str., 2
4Research Institute of Clinical and Experimental Lymphology – Branch of Federal Research Center Institute of Cytology and Genetics of SB RAS 630060, Novosibirsk, Timakov str., 2
5Research Institute of Clinical and Experimental Lymphology – Branch of Federal Research Center Institute of Cytology and Genetics of SB RAS 630060, Novosibirsk, Timakov str., 2
6Research Institute of Clinical and Experimental Lymphology – Branch of Federal Research Center Institute of Cytology and Genetics of SB RAS 630060, Novosibirsk, Timakov str., 2
7Research Institute of Clinical and Experimental Lymphology – Branch of Federal Research Center Institute of Cytology and Genetics of SB RAS 630060, Novosibirsk, Timakov str., 2
8Research Institute of Clinical and Experimental Lymphology – Branch of Federal Research Center Institute of Cytology and Genetics of SB RAS 630060, Novosibirsk, Timakov str., 2
9Research Institute of Clinical and Experimental Lymphology – Branch of Federal Research Center Institute of Cytology and Genetics of SB RAS 630060, Novosibirsk, Timakov str., 2
10Research Institute of Clinical and Experimental Lymphology – Branch of Federal Research Center Institute of Cytology and Genetics of SB RAS 630060, Novosibirsk, Timakov str., 2
11Research Institute of Clinical and Experimental Lymphology – Branch of Federal Research Center Institute of Cytology and Genetics of SB RAS 630060, Novosibirsk, Timakov str., 2
1. Kabakov A. V., Lykov A. P., Morozov D. V., Kazakov O. V., Poveshchenko A. F., Rajter T. V., Strunkin D. N., Konenkov V. I. Phenotypical characteristics of chemically induced mammary tumor. Bull. Exp. Biol. Med. 2017; 163 (4): 490-492. doi: 10.1007/s10517-017-3835-6
2. Ketlinskiy S.A., Simbirtsev A.S.Cytokines. Sankt-Peterburg: Foliant, 2008. [In Russian].
3. Poveshhenko A.F., Kazakov O.V., Orlov N.B., Poveshhenko O.V., Kim I.I., Bondarenko N.A., Solovyova I.G., Strunkin D.N., Kabakov A.V., Reiter T.V., Lykov A.P., Bogachev S.S., Pokushalov E.A., Konenkov V.I. Cytokines of lymph as markers of cancer progression and effectiveness of therapy in experimental breast tumors of rats WISTAR. Patologicheskaya fiziologiya i eksperimental'naya terapiya = Pathological physiology and experimental therapy. 2016; 60 (3): 68-75. [In Russian].
4. Sosnina A.V., Velikaya N.V., Autenshljus A.I. The role of cytokines in the pathogenesis of malignant neoplasms. Novosibirsk: Vektor-Best, 2013. 80 p. [In Russian].
5. Shipilov M.V., Ivanov V.V. Th17 response of an organism in acute respiratory viral infections of various origins. Tsitokiny i vospalenie = Cytokines and Inflammation. 2012; 11 (1): 109-113. [In Russian].
6. De Luca A., Gallo M., Aldinucci D., Ribatti D., Lamura L., D'Alessio A., De Filippi R., Pinto A., Normanno N. Role of the EGFR ligand/receptor system in the secretion of angiogenic factors in mesenchymal stem cells. J. Cell Physiol 2011; 226 (8): 2131-2138. doi: 10.1002/jcp.22548
7. De Luca A., Lamura L., Gallo M., Maffia V., Normanno N. Mesenchymal stem cell-derived interleukin-6 and vascular endothelial growth factor promote breast cancer cell migration. J Cell Biochem. 2012; 113 (11): 3363-3370. doi: 10.1002/jcb.24212
8. Esendagli G., Yilmaz G., Canpinar H., Gunel-Ozcan А., Guc M., Guc D. Coexistence of different tissue tumourigenesis in an N-methyl-N-nitrosourea-induced mammary carcinoma model: a histopathological report in Sprague-Dawley rats. Lab. Animals. 2009; 43 (1): 60-64. doi: 10.1258/la.2008.007076
9. Harrel M.I., Iritani B.M., Ruddell A. Tumor-induced sentinel lymph node lymphangiogenesis and increased lymph flow precede melanoma metastasis. Am. J. Pathol. 2007; 170 (2): 774-786. doi: 10.2353/ajpath.2007.060761
10. Ikezawa Y., Nakazawa M., Tamura C., Takahashi K, Minami M., Ikezawa Z. Cyclophosphamide decreases the number, percentage and the function of CD25+ CD4+ regulatory T cells, which suppress induction of contact hypersensitivity. J. Dermatol. Sci. 2005; 39 (2): 105-112. doi: 10.1016/j.jdermsci.2005.02.002
11. Meneses A., Verastegui E., Barrera J.L., de la Garza J., Hadden J.W. Lymph node histology in head and neck cancer: Impact of immunotherapy with IRX-2. Int. Immunol. 2003; 3 (8): 1083-1091. doi: 10.1016/S1567-5769(03)00017-1
12. Merendino R.A., Gangemi S., Ruello A., Bene A., Losi E., Lonbardo G., Purello-Dambrosio G. Serum levels of interleukin-18 and sICAM-1 in patients affected by breast cancer: preliminary considerations. Int. J. Biol. Markers. 2001; 16 (2): 126–129.
13. Molloy A.P., Martin F.T., Dwyer R.M., Griffin T.P., Murphy M., Barry F.P., O'Brien T., Kerin M.J. Mesenchymal stem cell secretion of chemokines during differentiation into osteoblasts, and their potential role in mediating interactions with breast cancer cells. Int. J. Cancer. 2009; 124 (2): 326–332. doi: 10.1002/ijc.23939
14. Sugama S., Conti B. Interleukin-18 and stress. Brain Res. Rev. 2008; 58 (1): 85-95. doi: 10.1016/j.brainresrev
15. Dhesy-Thind S., Fletcher G.G., Blanchette P.S., Clemons M.J., Dillmon M.S., Frank E.S., Gandhi S., Gupta R., Mates M., Moy B., Vandenberg T., Van Poznak C.H. Use of adjuvant bisphosphonates and other bone-modifying agents in breast cancer: A Cancer Care Ontario and American Society of Clinical Oncology clinical practice guideline. J. Clin. Oncol. 2017; 35 (18): 2062-2081. doi: 10.1200/JCO.2016.70.7257
16. Su Y.C., Rolph M.S., Cooley M.A., Sewell W.A. Cyclophosphamide augments inflammation by reducing immunosuppression in a mouse model of allergic airway disease. J. Allergy Clin. Immunol. 2006; 117 (3): 635-641. doi: 10.1016/j.jaci.2005.10.042
17. Takatsu K. Interleukin 5 and B cell differentiation. Cytokine Growth Factor Rev. 1998; 9: 25–35.
18. Tsubura A., Lai Y.C., Miki H., Sasaki T., Uehara N., Yuri T., Yoshizawa K. Animal models of N-Methyl-N-nitrosourea-induced mammary cancer and retinal degeneration with special emphasis on therapeutic trials. In Vivo. 2011; 25 (1): 11-22.